// App-Quantinova.ai

: Multi-parametric liquid biopsy analysis of circulating tumor cells (CTCs), cell-free DNA (cfDNA), and cell-free RNA (cfRNA) in metastatic castrate resistant prostate cancer (mCRPC).

Researchers

Presenter

  • Emmanuelle Hodara

Principal Investigators

  • Daniel Zainfeld

  • Gareth Morrison

  • Alexander Cunha

  • Yucheng Xu

  • John D. Carpten

  • Peter V. Danenberg

  • Paul W. Dempsey

  • Joshua Usher

  • KATHLEEN DANENBERG

  • Farideh Z. Bischoff

  • Aditi Khurana

  • Philip D. Cotter

  • Mathew Moore

  • Shelly Gunn

  • Tanya B. Dorff

  • David I. Quinn

  • Amir Goldkorn

Medical Centers

  • Keck School of Medicine of USC, Los Angeles, CA

  • USC Institute of Urology, Los Angeles, CA

  • University of Southern California, Los Angeles, CA

  • USC Keck School of Medicine Norris Comprehensive Cancer Center, Los Angeles, CA

  • Translational Genomics Research Institute, Phoenix, AZ

  • Cynvenio Biosystems Inc, Westlake Village, CA

  • Liquid Genomics, Inc., Torrance, CA

  • Liquid Genomics, Inc., Culver City, CA

  • Menarini Silicon Biosystems, Inc., La Jolla, CA

  • Research DX, Irvine, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

Disease

  • N/A

Biomarkers

  • Androgen receptor variant 7

  • Circulating tumor cells

  • Prostate Cancer Antigen 3

  • Plasma cell-free DNA

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved